Ashtead share price ticks up after buyback filing as NYSE shift nears

Ashtead share price ticks up after buyback filing as NYSE shift nears

London, January 15, 2026, 08:58 GMT — Regular session

  • Ashtead shares edged up 0.2% in early London trading
  • Company repurchased 70,900 shares for its treasury, according to the latest buyback update
  • Attention now shifts to the March 2 launch of a fresh $1.5 billion buyback program

Ashtead Group plc shares nudged up 0.2% to 5,280 pence (£52.80) in early London trade Thursday after the equipment rental company revealed another round of share buybacks. The firm purchased 70,900 shares for its treasury on Jan. 14, paying an average of 5,327.7247 pence each, with J.P. Morgan Securities serving as broker. (London South East)

This update matters now since buybacks remain one of the few immediate tools management can use as investors await larger milestones, like a planned U.S. relisting. When a company buys back its own shares, it reduces the number outstanding, which can boost earnings per share if profits stay steady.

For Ashtead, these filings are now routine morning material. They also tie into a bigger issue: does moving the company’s focus more toward U.S. investors affect its valuation, or simply its location?

The stock is attempting to find its footing following a sluggish session. Ashtead dropped 2.1% on Wednesday, closing at £52.70. That puts it roughly 10% under its 52-week peak of £58.50, hit on Jan. 2, according to MarketWatch data. (MarketWatch)

Ashtead runs primarily in North America and the UK through its Sunbelt Rentals brand. Investors frequently view it as a barometer for U.S. non-residential construction and major infrastructure projects. This connection means its shares can be volatile whenever forecasts for private building or large-scale projects change.

Back in December, CEO Brendan Horgan announced a fresh round of capital returns along with a shift to New York. “We are also announcing a new share buyback programme of $1.5bn commencing 2 March 2026,” he said, adding plans for an Investor Day in New York City that same March. Reuters later reported the buyback would align with the primary listing transferring to the New York Stock Exchange in March 2026. (Ashtead Group)

But buybacks only go so far as a shock absorber. If U.S. project starts slow down or clients delay work, fleet utilization and pricing can drop fast, with the market often hitting renters hard at the first sign of a downturn.

Stock Market Today

  • BridgeBio Pharma Valuation After Attruby Uptake, BBP-418 Data, and Late-Stage Pipeline Momentum
    January 15, 2026, 6:33 AM EST. BridgeBio Pharma (BBIO) has drawn fresh attention after reporting more than 6,600 prescriptions for its ATTR-CM therapy Attruby, releasing interim Phase 3 data for BBP-418, and outlining a new TTR amyloid depleter program. Our latest analysis notes a 90-day share-price gain of 41.6% and a 3-year total shareholder return, with the stock near US$77.90. The fair value estimate stands around US$84.65, implying upside if late-stage programs convert to revenue and earnings. Analysts' consensus price target is US$63.81, with a range from US$41.00 to US$95.00. Risks include durability of Attruby, negative trial data, and regulatory delays. Valuation shows BridgeBio trading at a discount to our fair value, but a high P/S ratio (~42.4x vs 26.8x fair). A premium valuation hinges on execution and margin expansion.
Diageo stock dips as China asset-sale talk lingers — what to watch next
Previous Story

Diageo stock dips as China asset-sale talk lingers — what to watch next

Fresnillo stock slides nearly 4% as silver cools — Citi target and Probe deal steps in focus
Next Story

Fresnillo stock slides nearly 4% as silver cools — Citi target and Probe deal steps in focus

Go toTop